Evidence map›Paper›PMID 32996267›Full record

ArticleEMBO molecular medicine2020

COVID-19: a pandemic experience that illuminates potential reforms to health research.

Hannah N Kozlowski, Michael E Farkouh, Meredith S Irwin, Laszlo G Radvanyi, Aaron D Schimmer, Uri Tabori, Norman D Rosenblum

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EMBO molecular medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hannah N KozlowskiBiomedical Engineering, University of Toronto, Toronto, ON, Canada.
Michael E FarkouhPeter Munk Cardiac Centre, Heart and Stroke Richard Lewar Centre, University of Toronto, Toronto, ON, Canada.
Meredith S IrwinDepartment of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Laszlo G RadvanyiOntario Institute for Cancer Research, Toronto, ON, Canada.
Aaron D SchimmerPrincess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.
Uri TaboriDepartment of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Norman D RosenblumDepartment of Paediatrics, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.ORCID 0000-0003-1767-6464

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

COVID-19 has halted research around the globe and forced researchers out of their laboratories. Non-emergency medical appointments were canceled. Ongoing clinical trials were challenged to create new modes of operation while public pressure mounted to find therapeutic options against COVID-19. Yet, the inability to conduct research during COVID-19 was overcome with cooperation, resource sharing, and compassion, which provides important lessons on how to improve health related research as we enter a new normal.

Indexed as

ResearchCOVID-19EmpathyHumansInformation DisseminationIntersectoral CollaborationPandemicsSARS-CoV-2

Identifiers

PMID32996267
PMCPMC7536940

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.